Who owns GT BIOPHARMA INC COM NEW?
- Ticker: GTBP
- CUSIP Number: 36254l308
Tip: Access positions for across all investors
Analyze quarterly positions in Gt Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gt Biopharma stock
Who bought or sold GT BIOPHARMA INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | 1.1M | $47M | 100% | Mar 2024 |
|
| Vanguard Group | 21k | $91k | 100% | Mar 2024 |
|
| Bank Of Montreal | 20k | $102k | 100% | Mar 2024 |
|
| Geode Capital Management | 11k | $50k | 100% | Mar 2024 |
|
| BlackRock | 10k | $45k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 10k | $45k | 100% | Mar 2024 |
|
| Tower Research Capital | 2.3k | $10k | 100% | Mar 2024 |
|
| UBS Group | 1.0k | $4.1k | 100% | Mar 2024 |
|
| Morgan Stanley | 266.00 | $1.2k | 100% | Mar 2024 |
|
| FMR | 61.00 | $270.998600 | 100% | Mar 2024 |
|
| Advisor Group Holdings | 32.00 | $141.715200 | 100% | Mar 2024 |
|
| Bank of America Corporation | 17.00 | $68.000000 | 100% | Mar 2024 |
|
| Blue Bell Private Wealth Management | 10.00 | $44.000000 | 100% | Mar 2024 |
|
| Royal Bank of Canada | 7.00 | $0 | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 6.00 | $27.000000 | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 1.00 | $4.000000 | 100% | Mar 2024 |
|
| Front Row Advisors | 1.00 | $4.000000 | -98% | Mar 2024 |
|
Who sold out of Gt Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Advisory Services Network | Dec 2023 | 150.00 | $37.995000 |